EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

mRNAs encoding self-DNA reactive cGAS enhance the immunogenicity of lipid nanoparticle vaccines

Dania Zhivaki iD, Emily A Gosselin iD, Debrup Sengupta, Holly Concepcion, Chisom Arinze, Jonathan Chow, Anastasia Nikiforov, Veronica Komoroski, Carolyn MacFarlane, Caitlin Sullivan, Jonathan C Kagan iD

mBio · 2023

DOI: 10.1128/mbio.02506-23 ↗

Kurz gefasst

Fachartikel in der Zeitschrift mBio, 2023. Verfasst von Dania Zhivaki und 10 weiteren Autor:innen. Beteiligte Einrichtung: Corner Therapeutics, Watertown, Massachusetts, USA. Hauptthemen laut MEDLINE: Nanoparticles, Adjuvants, Immunologic, RNA, Messenger, Nucleotidyltransferases. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lipid nanoparticle (LNP)-encapsulated mRNAs have emerged as effective vaccination tools to stimulate immunity. The most common application of this technology is to deliver mRNAs that encode antigenic proteins to dendritic cells (DCs), which then stimulate antigen-specific lymphocyte responses. It is unclear whether other immunostimulatory DC activities necessary for vaccine efficacy, beyond antigen presentation, can be induced via mRNA-encoded proteins. Herein, we report an mRNA encoding a self-DNA reactive variant of the enzyme cyclic GMP-AMP synthase (cGAS), known as cGAS∆N. cGAS∆N produces the cyclic dinucleotide cGAMP upon binding intra-mitochondrial DNA. cGAMP binds the protein STING, which activates innate immune responses that stimulate T cells. We found that when delivered to DCs via LNPs, mRNA-encoded cGAS∆N induced the upregulation of chemokine receptors, T cell costimulatory molecules, major histocompatibility complex proteins, pro-inflammatory cytokines and type I interferons from murine and human DCs. These activities exceeded the immunostimulatory activities of mRNA-encoded antigens delivered via LNPs. Co-immunization of mice with antigen-LNPs and cGAS∆N-LNPs led to the robust production of antigen-specific IFNγ-producing T cells. These T cell responses were durable and circulated through the lymphatics, blood, and lungs. Immunizations with antigen-LNPs alone, akin to what are used in the clinic, stimulated weak and transient T cell responses. Antibody responses to antigen-LNPs were biased towards type I isotypes when co-injected with cGAS∆N-LNPs, as compared to immunizations with antigen-LNPs alone. These findings establish the enzyme cGAS∆N as a catalytic adjuvant, which may prove useful in enhancing the immunogenicity of nucleic acid-based vaccines. IMPORTANCE Nucleic acid-based vaccines hold promise in preventing infections and treating cancer. The most common use of this technology is to encode antigenic proteins on mRNAs that are delivered to cells via lipid nanoparticle (LNP) formulations. In this study, we discovered that immunostimulatory proteins can also be encoded on mRNAs in LNPs. We found that an active mutant of the enzyme cGAS, referred to as cGAS∆N, acts as a catalytic adjuvant in LNP-encapsulated mRNA vaccines. The delivery of cGAS∆N mRNA via LNPs in combination with antigen mRNA-LNPs led to durable antigen-specific IFNγ-producing T cells that exceeded the efficiency of antigen-LNPs similar to those currently used in the clinic. This strategy did not compromise B cell responses; rather it induced Th1-biased antibody isotypes. This work unveils new vaccine design strategies using mRNA-encoded catalytic adjuvants that could be ideal for generating CD8 + T cell and B cell responses for immunotherapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesAdjuvants, ImmunologicRNA, MessengerNucleotidyltransferasesAnimalsMiceMice, Inbred C57BLB-LymphocytesFemaleCD8-Positive T-LymphocytesLipidsmRNA VaccinesImmunogenicity, VaccineHumansNanovaccinesLiposomesCyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase

Stichwörter der Autor:innen

adjuvantscGAScatalytic adjuvantinnate immunitymRNAvaccines

Substanzen

Adjuvants, ImmunologicRNA, MessengerNucleotidyltransferasesLipidsmRNA VaccinesNanovaccinesLiposomesLipid NanoparticlescGAS protein, mouseCyclic Guanosine Monophosphate-Adenosine Monophosphate Synthase

Autor:innen und Institutionen

  • Corner Therapeutics, Watertown, Massachusetts, USA.

ORCID-Profile: Dania Zhivaki, Emily A Gosselin, Jonathan C Kagan

Zitieren

APA

Zhivaki, D., Gosselin, E. A., Sengupta, D., Concepcion, H., Arinze, C., Chow, J., Nikiforov, A., Komoroski, V., MacFarlane, C., Sullivan, C., & Kagan, J. C. (2023). mRNAs encoding self-DNA reactive cGAS enhance the immunogenicity of lipid nanoparticle vaccines. mBio. https://doi.org/10.1128/mbio.02506-23

Vancouver

Zhivaki D, Gosselin EA, Sengupta D, Concepcion H, Arinze C, Chow J, et al. mRNAs encoding self-DNA reactive cGAS enhance the immunogenicity of lipid nanoparticle vaccines. mBio. 2023. doi:10.1128/mbio.02506-23

BibTeX
@article{Zhivaki2023,
  author = {Zhivaki, Dania and Gosselin, Emily A and Sengupta, Debrup and Concepcion, Holly and Arinze, Chisom and Chow, Jonathan and Nikiforov, Anastasia and Komoroski, Veronica and MacFarlane, Carolyn and Sullivan, Caitlin and Kagan, Jonathan C},
  title = {mRNAs encoding self-DNA reactive cGAS enhance the immunogenicity of lipid nanoparticle vaccines},
  journal = {mBio},
  year = {2023},
  doi = {10.1128/mbio.02506-23}
}
Kostenlos starten →